N@N

China Kanghui Holdings Announces Participation in Upcoming Investor Conferences

^{Published on 2010-10-27 13:10:57 - Market Wire}
 

CHANGZHOU, China--([ BUSINESS WIRE ])--China Kanghui Holdings (NYSE: KH) (aKanghuia or the aCompanya), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced its participation at the following investor conferences:

• Oppenheimer 21st Annual Healthcare Conference, to be held November 2-3, 2010 at the Waldorf Astoria hotel in New York. The Companya™s Chief Business Officer, Dr. Chen Yu, has been invited to speak on the panel discussion at 8:50 am ET on Wednesday, November 3, 2010 and will meet with institutional investors throughout the day.
• Morgan Stanley Asia Pacific Summit, to be held November 9-11, 2010 at the Mandarin Oriental Hotel in Singapore. The Companya™s Chief Financial Officer, Ms. Sarah Wang, will present and meet with institutional investors at the conference.
• Credit Suisse Asian Healthcare Conference, to be held November 16-17, 2010 at the Conrad Hotel in Hong Kong, China. The Companya™s Chief Financial Officer, Ms. Sarah Wang, is scheduled to present at 11:00 am local time on Wednesday, November 17, 2010, and will meet with institutional investors on both days.

For further details, please contact your respective institutional sales representative.

About China Kanghui Holdings

Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghuia™s products are distributed in 24 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit [ www.kanghui.com ].